Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer
British Journal of Cancer, 09/17/09
Lugli A et al. – The CD8+ lymphocyte : tumour–budding index is an independent prognostic factor in colorectal cancer and a promising approach for a future prognostic score for patients with this disease.
Related Articles
Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 72%
Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk
Cancer Causes and Control, 10/02/09
Relevance Score: 72%
P73 expression and its clinical significance in colorectal cancer
Colorectal Disease, 10/19/09
Relevance Score: 71%
trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II
Cancer Causes and Control, 10/28/09
Relevance Score: 70%
Association of clinicopathological features with UbcH10 expression in colorectal cancer
Journal of Cancer Research & Clinical Oncology, 10/01/09
Relevance Score: 70%
Today in Gastrointestinal/Hepatic...keeping you current
Receive free subspecialty "5-minute updates" via email
Zinc Influences the Innate Immune Responses in Children with Enterotoxigenic Escherichia coli-Induced Diarrhea
The Journal of Nutrition, 03/19/10
The geoepidemiology of autoimmune intestinal diseases
Autoimmunity Reviews, 03/19/10
New genetic associations detected in a host response study to hepatitis B vaccine
Genes and Immunity, 03/19/10
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Overview of hypersensitivity to cancer therapies
Community Oncology , 03/19/10
Radioimmunotherapy: a promising treatment strategy for follicular lymphoma
Community Oncology , 03/19/10
CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells
Immunology & Cell Biology, 03/19/10
Article Search
Sponsor
Sponsor


See Latest Articles


